Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating the combination of anlotinib and penpulimab as second-line therapy for small cell lung cancer after platin…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors [Phase 2]
ClinicalTrials.gov update for QUILT-3.055, a Phase 2 study of combination immunotherapies in patients who previously received immune checkpo…
-
EMA approval · 2026-01-12EMA Authorised: Hetronifly (serplulimab) — Accord Healthcare S.L.U.
EMA authorised Hetronifly (serplulimab) for small cell lung cancer, with Accord Healthcare S.L.U. as the marketing authorisation holder. The…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors [Phase 1, Phase 2]
A first-in-human Phase 1/2 trial of JAB-8263 in adults with advanced tumors is currently recruiting across multiple cancer types including l…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: JAB-2485 Activity in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Jacobio's JAB-2485 is being studied in Phase 1/2 for adults with advanced solid tumors, including breast cancer subtypes and small cell lung…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
This clinical trial update reports on real-world outcomes and safety of atezolizumab in routine practice. It includes patients with urotheli…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating PET/CT imaging of small cell lung cancer with the radiotracer 89Zr-DFO-SC16.56, sponsored by Me…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial update evaluating ABP1011T tablets for small cell lung cancer and other advanced solid tumors; recruitment is ongoing…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer [Phase 3]
This clinical trial update reports results from a Phase 3 study comparing tarlatamab to standard-of-care chemotherapy in relapsed small cell…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial of ZG006 for Small cell lung cancer and neuroendocrine carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
A completed clinical trial evaluating CXCR4 PET/CT as a predictor of outcomes in limited-stage small cell lung cancer.
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer [Phase 3]
A phase 3 study compares ZG006 with investigator-selected chemotherapy in relapsed small cell lung cancer. The trial is currently recruiting…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma [Phase 1, Phase 2]
This clinical trial update reports that ZG005 and ZG006 are being studied in Phase 1/Phase 2 trials for small cell lung cancer and neuroendo…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer [Phase 3]
Phase III trial evaluating maintenance lurbinectedin in combination with atezolizumab versus atezolizumab alone in extensive-stage small-cel…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer [Phase 3]
Phase III open-label study comparing maintenance lurbinectedin plus atezolizumab vs atezolizumab alone in extensive-stage small-cell lung ca…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer
This entry notes a real-world study of toripalimab for extensive-stage small cell lung cancer, with the study currently not recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial) [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating irinotecan in combination with a CDC2-like kinase inhibitor (the SLICK trial) for small cell l…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) [Phase 2]
This update describes a Phase 2 study of tarlatamab in relapsed/refractory small cell lung cancer; the trial is currently active but not rec…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients [NA]
A completed clinical trial examined detection of plasma DNA in patients with non-small cell lung cancer and small cell lung cancer.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update notes a phase 1/phase 2 study evaluating the combination of lurbinectedin with osimertinib in transformed small c…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer [Phase 2]
Phase 2 clinical trial update evaluating nivolumab plus temozolomide in patients with recurrent or refractory small-cell lung cancer or adva…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: A Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy Progression [Phase 2]
This document reports a Phase 2 prospective, single-arm exploratory study evaluating the investigational drug IBI363 in patients with extens…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab [Phase 3]
A Phase 3 trial is evaluating Tarlatamab plus Durvalumab versus Durvalumab alone as first-line therapy for extensive-stage small-cell lung c…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating the PLK1 inhibitor Onvansertib in relapsed small cell lung cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluating ST-001 nanoFenretinide in relapsed or refractory small cell lung cancer is currently recruiting.